“…56,57 Taken together, best current evidence suggests that arthroscopic and MRI-based scoring and grading systems for articular cartilage and whole-joint pathology are useful and important clinical tools, but can only provide a cross-sectional status, or "snapshot," and do not allow for determination of disease phenotype or progression. [2][3][4][5][6][7][8]58 Because clinical data are not routinely available until patients seek care for symptoms, most classification and staging algorithms are primarily informed by late-stage disease, which leads to ambiguity, overlap, and generalization, relegating physicians and patients to incomplete, possibly inaccurate, data for decision making regarding type and timing of treatment. [59][60][61][62][63][64][65][66][67][68] As such, more nuanced, earlier, longitudinal analytical methods, ideally including controls for relevant cohorts, which incorporate articular cartilage lesions features, whole-joint status, and whole-patient variables are needed to fill this unmet need in orthopaedic health care.…”